Remedent

Remedent Receivables

The Accounts Receivable of Remedent (REMI) as of Nov 19, 2026 is 2.31 M USD. In the previous year, Accounts Receivable was 329,300.00 USD — a change of 601.49% (higher).

Receivables

2.31 MUSD

YoY

601.49%

Last updated:

Accounts Receivable of Remedent is 2022 2.31 M USD. Accounts Receivable of Remedent was 2021 329,300.00 USD. It decreases by 601.49% higher compared to the previous year.

The Remedent Receivables history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Receivables
Date
Receivables
Jan 1, 2014
790,000.00 USD
Jan 1, 2015
847,100.00 USD
Jan 1, 2016
977,800.00 USD
Jan 1, 2017
943,300.00 USD
Jan 1, 2018
1.16 M USD
Jan 1, 2019
233,900.00 USD
Jan 1, 2020
329,300.00 USD
Jan 1, 2022
2.31 M USD
The Remedent Receivables history
YEARReceivablesYoY
2.31 MUSD+601.49%
329,300.00USD+40.79%
233,900.00USD-79.79%
1.16 MUSD+22.70%
943,300.00USD-3.53%
977,800.00USD+15.43%
847,100.00USD+7.23%
790,000.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Remedent Stock analysis

What does Remedent do? Remedent Inc is a company specialized in the development, manufacturing, and marketing of innovative dental products. It was founded in 1997 by Jürgen Steenwelle and Philippe de Bergeyck, with its headquarters in Mariakerke, Belgium. The company started with the creation of the GlamSmile veneer system, which revolutionized aesthetic dentistry. Remedent expanded its product portfolio to include teeth whitening systems, dental implants, dental instruments, and dental software solutions. The company aims to revolutionize the dental market with innovative technologies and materials. Remedent works closely with dental professionals worldwide to ensure the highest quality standards. It has locations in Europe, the USA, and Asia. Partnership with dentists and clinics is a key aspect of Remedent's business model, offering training and certifications to ensure proper and effective use of their products. The company is focused on global market expansion through strategic acquisitions and mergers to grow its customer base and promote technological advancements. Remedent has achieved impressive growth and success in a highly competitive market, remaining a significant provider of dental products and pursuing a strong growth strategy. Remedent is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Remedent stock

Accounts Receivable of Remedent is 2.31 M USD in 2022.

Accounts Receivable of Remedent changed from 329,300.00 USD to 2.31 M USD, representing a 601.49% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Accounts Receivable Remedent since 2006 – with annual values, charts, and detailed analysis.

Receivables represent money owed to the company by customers for goods or services delivered. High receivables relative to revenue may indicate collection issues.

Accounts Receivable's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Accounts Receivable's Remedent historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Remedent

All Key Metrics — Remedent